CD4<sup>+</sup> T-cell responses directed towards A/H5N1-derived haemagglutinin peptides increase in patients with seasonal influenza A virus infection. [PDF]
Allen LF +14 more
europepmc +1 more source
Advances in the Development of a Universal Influenza Vaccine. [PDF]
Mudaly P, Lee M, Bhatta A, Thompson C.
europepmc +1 more source
Immunogenicity of a Multi-Epitope Influenza Composite Peptide Vaccine Targeting Human, Swine, and Avian Viruses: Advancing Pandemic Preparedness. [PDF]
Rikhi N +6 more
europepmc +1 more source
Assessment of influenza virus and coronavirus tropism, replication competence and disease severity in <i>ex vivo</i> and <i>in vitro</i> cultures of the human respiratory tract. [PDF]
Kuok DIT +11 more
europepmc +1 more source
Perspective on human diagnostic and national reference laboratory preparedness for zoonotic influenza in Europe. [PDF]
Felix Garza ZC +5 more
europepmc +1 more source
Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection. [PDF]
Kikawa C +23 more
europepmc +1 more source
Related searches:
Transmission of influenza A in human beings
The Lancet Infectious Diseases, 2007Planning for the next influenza pandemic is occurring at many levels throughout the world, spurred on by the recent spread of H5N1 avian influenza in Asia, Europe, and Africa. Central to these planning efforts in the health-care sector are strategies to minimise the transmission of influenza to health-care workers and patients.
Gabrielle, Brankston +4 more
+7 more sources
A “universal” human influenza A vaccine
Virus Research, 2004We have previously reported on a universal human influenza A vaccine, based on the external domain of the transmembrane viral M2-protein (M2e) [Nature Medicine 5 (1999) 1119]. M2-protein is scarcely present on the virus but is abundantly expressed on virus-infected cells.
W, Fiers +4 more
openaire +2 more sources

